DSGN Latest Press Releases

-- May 28, 2026 --

Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- May 18, 2026 --

Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia Globe Newswire 7:00 AM

-- May 17, 2026 --

Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich's Ataxia on Monday, May 18, 2026 Globe Newswire 4:00 PM

-- April 28, 2026 --

Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates Globe Newswire 4:01 PM

-- March 9, 2026 --

Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates Globe Newswire 4:01 PM

-- February 18, 2026 --

Design Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software